IRIDEX (IRIX) Competitors

$1.01 +0.01 (+1.00%)

Closing price 04:00 PM Eastern

Extended Trading

$1.03 +0.02 (+1.98%)

As of 07:55 PM Eastern

IRIX vs. BDMD, OM, DRIO, APT, and MDAI

Should you buy IRIDEX stock or one of its competitors? MarketBeat compares IRIDEX with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with IRIDEX include Baird Medical Investment (BDMD), Outset Medical (OM), DarioHealth (DRIO), Alpha Pro Tech (APT), and Spectral AI (MDAI). These companies are all part of the "medical equipment" industry.

How does IRIDEX compare to Baird Medical Investment?

Baird Medical Investment (NASDAQ:BDMD) and IRIDEX (NASDAQ:IRIX) are both small-cap medical equipment companies, but which is the superior business? We will contrast the two businesses based on the strength of their institutional ownership, dividends, risk, earnings, analyst recommendations, media sentiment, valuation and profitability.

Baird Medical Investment has a beta of -1.18, meaning that its stock price is 218% less volatile than the broader market. Comparatively, IRIDEX has a beta of 0.64, meaning that its stock price is 36% less volatile than the broader market.

In the previous week, IRIDEX had 7 more articles in the media than Baird Medical Investment. MarketBeat recorded 7 mentions for IRIDEX and 0 mentions for Baird Medical Investment. IRIDEX's average media sentiment score of 0.59 beat Baird Medical Investment's score of 0.00 indicating that IRIDEX is being referred to more favorably in the news media.

Company	Overall Sentiment
Baird Medical Investment	Neutral
IRIDEX	Positive

19.8% of Baird Medical Investment shares are held by institutional investors. Comparatively, 20.1% of IRIDEX shares are held by institutional investors. 78.9% of Baird Medical Investment shares are held by company insiders. Comparatively, 8.6% of IRIDEX shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

Baird Medical Investment has higher earnings, but lower revenue than IRIDEX.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Baird Medical Investment	$22.54M	2.98	N/A	N/A	N/A
IRIDEX	$52.67M	0.33	-$4.44M	-$0.26	N/A

Baird Medical Investment has a net margin of 0.00% compared to IRIDEX's net margin of -6.23%. Baird Medical Investment's return on equity of 0.00% beat IRIDEX's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Baird Medical Investment	N/A	N/A	N/A
IRIDEX	-6.23%	-1,204.74%	-11.16%

IRIDEX has a consensus price target of $3.00, indicating a potential upside of 197.03%. Given IRIDEX's stronger consensus rating and higher possible upside, analysts clearly believe IRIDEX is more favorable than Baird Medical Investment.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Baird Medical Investment	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
IRIDEX	1 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00

Summary

IRIDEX beats Baird Medical Investment on 8 of the 13 factors compared between the two stocks.

How does IRIDEX compare to Outset Medical?

IRIDEX (NASDAQ:IRIX) and Outset Medical (NASDAQ:OM) are both small-cap medical equipment companies, but which is the better stock? We will compare the two businesses based on the strength of their analyst recommendations, dividends, institutional ownership, earnings, profitability, risk, media sentiment and valuation.

IRIDEX has higher earnings, but lower revenue than Outset Medical. IRIDEX is trading at a lower price-to-earnings ratio than Outset Medical, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
IRIDEX	$52.67M	0.33	-$4.44M	-$0.26	N/A
Outset Medical	$119.48M	0.66	-$81.65M	-$4.16	N/A

In the previous week, IRIDEX had 2 more articles in the media than Outset Medical. MarketBeat recorded 7 mentions for IRIDEX and 5 mentions for Outset Medical. IRIDEX's average media sentiment score of 0.59 beat Outset Medical's score of -0.18 indicating that IRIDEX is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
IRIDEX	0 Very Positive mention(s)	1 Positive mention(s)	5 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Outset Medical	1 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

IRIDEX currently has a consensus price target of $3.00, indicating a potential upside of 197.03%. Outset Medical has a consensus price target of $10.00, indicating a potential upside of 134.74%. Given IRIDEX's higher possible upside, equities research analysts plainly believe IRIDEX is more favorable than Outset Medical.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
IRIDEX	1 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00
Outset Medical	1 Sell rating(s)	1 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.40

IRIDEX has a net margin of -6.23% compared to Outset Medical's net margin of -63.65%. Outset Medical's return on equity of -56.13% beat IRIDEX's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
IRIDEX	-6.23%	-1,204.74%	-11.16%
Outset Medical	-63.65%	-56.13%	-27.45%

20.1% of IRIDEX shares are owned by institutional investors. 8.6% of IRIDEX shares are owned by company insiders. Comparatively, 2.5% of Outset Medical shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

IRIDEX has a beta of 0.64, suggesting that its stock price is 36% less volatile than the broader market. Comparatively, Outset Medical has a beta of 1.92, suggesting that its stock price is 92% more volatile than the broader market.

Summary

IRIDEX beats Outset Medical on 9 of the 16 factors compared between the two stocks.

How does IRIDEX compare to DarioHealth?

DarioHealth (NASDAQ:DRIO) and IRIDEX (NASDAQ:IRIX) are both small-cap medical equipment companies, but which is the superior business? We will contrast the two businesses based on the strength of their media sentiment, institutional ownership, valuation, dividends, analyst recommendations, earnings, profitability and risk.

DarioHealth currently has a consensus target price of $10.50, indicating a potential upside of 36.61%. IRIDEX has a consensus target price of $3.00, indicating a potential upside of 197.03%. Given IRIDEX's higher probable upside, analysts clearly believe IRIDEX is more favorable than DarioHealth.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
DarioHealth	1 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00
IRIDEX	1 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00

IRIDEX has a net margin of -6.23% compared to DarioHealth's net margin of -192.23%. DarioHealth's return on equity of -60.52% beat IRIDEX's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
DarioHealth	-192.23%	-60.52%	-37.08%
IRIDEX	-6.23%	-1,204.74%	-11.16%

DarioHealth has a beta of 1.09, indicating that its stock price is 9% more volatile than the broader market. Comparatively, IRIDEX has a beta of 0.64, indicating that its stock price is 36% less volatile than the broader market.

33.4% of DarioHealth shares are held by institutional investors. Comparatively, 20.1% of IRIDEX shares are held by institutional investors. 3.5% of DarioHealth shares are held by company insiders. Comparatively, 8.6% of IRIDEX shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

IRIDEX has higher revenue and earnings than DarioHealth. IRIDEX is trading at a lower price-to-earnings ratio than DarioHealth, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
DarioHealth	$22.36M	2.51	-$41.71M	-$8.88	N/A
IRIDEX	$52.67M	0.33	-$4.44M	-$0.26	N/A

In the previous week, IRIDEX had 7 more articles in the media than DarioHealth. MarketBeat recorded 7 mentions for IRIDEX and 0 mentions for DarioHealth. IRIDEX's average media sentiment score of 0.59 beat DarioHealth's score of 0.38 indicating that IRIDEX is being referred to more favorably in the news media.

Company	Overall Sentiment
DarioHealth	Neutral
IRIDEX	Positive

Summary

IRIDEX beats DarioHealth on 9 of the 14 factors compared between the two stocks.

How does IRIDEX compare to Alpha Pro Tech?

IRIDEX (NASDAQ:IRIX) and Alpha Pro Tech (NYSE:APT) are both small-cap medical equipment companies, but which is the better business? We will compare the two businesses based on the strength of their earnings, analyst recommendations, dividends, institutional ownership, media sentiment, valuation, profitability and risk.

IRIDEX has a beta of 0.64, meaning that its share price is 36% less volatile than the broader market. Comparatively, Alpha Pro Tech has a beta of 0.8, meaning that its share price is 20% less volatile than the broader market.

Alpha Pro Tech has a net margin of 6.99% compared to IRIDEX's net margin of -6.23%. Alpha Pro Tech's return on equity of 6.70% beat IRIDEX's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
IRIDEX	-6.23%	-1,204.74%	-11.16%
Alpha Pro Tech	6.99%	6.70%	5.76%

20.1% of IRIDEX shares are held by institutional investors. Comparatively, 22.7% of Alpha Pro Tech shares are held by institutional investors. 8.6% of IRIDEX shares are held by company insiders. Comparatively, 15.0% of Alpha Pro Tech shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

In the previous week, IRIDEX had 5 more articles in the media than Alpha Pro Tech. MarketBeat recorded 7 mentions for IRIDEX and 2 mentions for Alpha Pro Tech. Alpha Pro Tech's average media sentiment score of 0.89 beat IRIDEX's score of 0.59 indicating that Alpha Pro Tech is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
IRIDEX	0 Very Positive mention(s)	1 Positive mention(s)	5 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Alpha Pro Tech	1 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

IRIDEX currently has a consensus price target of $3.00, indicating a potential upside of 197.03%. Given IRIDEX's stronger consensus rating and higher probable upside, analysts plainly believe IRIDEX is more favorable than Alpha Pro Tech.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
IRIDEX	1 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00
Alpha Pro Tech	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00

Alpha Pro Tech has higher revenue and earnings than IRIDEX. IRIDEX is trading at a lower price-to-earnings ratio than Alpha Pro Tech, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
IRIDEX	$52.67M	0.33	-$4.44M	-$0.26	N/A
Alpha Pro Tech	$59.91M	1.05	$4.19M	$0.35	17.66

Summary

Alpha Pro Tech beats IRIDEX on 12 of the 16 factors compared between the two stocks.

How does IRIDEX compare to Spectral AI?

IRIDEX (NASDAQ:IRIX) and Spectral AI (NASDAQ:MDAI) are both small-cap medical equipment companies, but which is the better stock? We will compare the two companies based on the strength of their profitability, analyst recommendations, valuation, institutional ownership, media sentiment, dividends, earnings and risk.

20.1% of IRIDEX shares are held by institutional investors. Comparatively, 67.1% of Spectral AI shares are held by institutional investors. 8.6% of IRIDEX shares are held by insiders. Comparatively, 13.7% of Spectral AI shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

IRIDEX has higher revenue and earnings than Spectral AI. Spectral AI is trading at a lower price-to-earnings ratio than IRIDEX, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
IRIDEX	$52.67M	0.33	-$4.44M	-$0.26	N/A
Spectral AI	$19.65M	4.28	-$7.57M	-$0.53	N/A

IRIDEX currently has a consensus price target of $3.00, indicating a potential upside of 197.03%. Spectral AI has a consensus price target of $3.00, indicating a potential upside of 13.64%. Given IRIDEX's higher possible upside, equities analysts clearly believe IRIDEX is more favorable than Spectral AI.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
IRIDEX	1 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00
Spectral AI	1 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00

IRIDEX has a net margin of -6.23% compared to Spectral AI's net margin of -85.58%. Spectral AI's return on equity of 0.00% beat IRIDEX's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
IRIDEX	-6.23%	-1,204.74%	-11.16%
Spectral AI	-85.58%	N/A	-72.97%

In the previous week, IRIDEX and IRIDEX both had 7 articles in the media. IRIDEX's average media sentiment score of 0.59 beat Spectral AI's score of 0.39 indicating that IRIDEX is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
IRIDEX	0 Very Positive mention(s)	1 Positive mention(s)	5 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Spectral AI	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

IRIDEX has a beta of 0.64, meaning that its share price is 36% less volatile than the broader market. Comparatively, Spectral AI has a beta of 1.16, meaning that its share price is 16% more volatile than the broader market.

Summary

IRIDEX beats Spectral AI on 7 of the 12 factors compared between the two stocks.

Get IRIDEX News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding IRIX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

IRIX vs. The Competition

Export

Metric	IRIDEX	LASERS Industry	Computer Sector	NASDAQ Exchange
Market Cap	$17.41M	$940.71M	$38.96B	$12.29B
Dividend Yield	N/A	N/A	3.21%	5.32%
P/E Ratio	-5.32	43.67	159.82	22.73
Price / Sales	0.33	160.15	628.83	77.74
Price / Cash	N/A	45.13	46.86	56.13
Price / Book	-14.43	24.14	10.40	7.01
Net Income	-$4.44M	-$16.97M	$1.06B	$335.05M
7 Day Performance	N/A	1.56%	0.54%	-0.29%
1 Month Performance	-5.61%	-3.94%	5.05%	1.15%
1 Year Performance	-0.98%	7.02%	168.52%	34.79%

IRIDEX Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
IRIX IRIDEX	2.5986 of 5 stars	$1.01 +1.0%	$3.00 +197.0%	-2.0%	$17.41M	$52.67M	N/A	120	News Coverage Earnings Report Analyst Downgrade
BDMD Baird Medical Investment	N/A	$1.71 +0.2%	N/A	-67.3%	$69.71M	$22.54M	N/A	N/A	Short Interest Decrease Gap Down
OM Outset Medical	2.2667 of 5 stars	$3.75 +2.8%	$10.00 +166.4%	-77.5%	$69.60M	$119.48M	N/A	520
DRIO DarioHealth	2.4993 of 5 stars	$7.23 -16.7%	$35.00 +384.1%	-42.0%	$63.91M	$22.36M	N/A	200	High Trading Volume
APT Alpha Pro Tech	N/A	$6.01 -5.3%	N/A	+38.5%	$62.38M	$59.91M	16.50	120

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:IRIX) was last updated on 5/21/2026 by MarketBeat.com Staff.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

IRIDEX (IRIX) Competitors

IRIX vs. BDMD, OM, DRIO, APT, and MDAI

How does IRIDEX compare to Baird Medical Investment?

Summary

How does IRIDEX compare to Outset Medical?

Summary

How does IRIDEX compare to DarioHealth?

Summary

How does IRIDEX compare to Alpha Pro Tech?

Summary

How does IRIDEX compare to Spectral AI?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

IRIX vs. The Competition

IRIDEX Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

IRIDEX (IRIX) Competitors

IRIX vs. BDMD, OM, DRIO, APT, and MDAI

How does IRIDEX compare to Baird Medical Investment?

Which has more risk & volatility, BDMD or IRIX?

Does the media refer more to BDMD or IRIX?

Do institutionals & insiders believe in BDMD or IRIX?

Which has higher valuation & earnings, BDMD or IRIX?

Is BDMD or IRIX more profitable?

Do analysts rate BDMD or IRIX?

Summary

How does IRIDEX compare to Outset Medical?

Which has higher valuation and earnings, IRIX or OM?

Does the media favor IRIX or OM?

Do analysts rate IRIX or OM?

Is IRIX or OM more profitable?

Do institutionals & insiders believe in IRIX or OM?

Which has more volatility and risk, IRIX or OM?

Summary

How does IRIDEX compare to DarioHealth?

Do analysts rate DRIO or IRIX?

Is DRIO or IRIX more profitable?

Which has more risk and volatility, DRIO or IRIX?

Do institutionals & insiders have more ownership in DRIO or IRIX?

Which has preferable valuation and earnings, DRIO or IRIX?

Does the media prefer DRIO or IRIX?

Summary

How does IRIDEX compare to Alpha Pro Tech?

Which has more risk and volatility, IRIX or APT?

Is IRIX or APT more profitable?

Do institutionals and insiders believe in IRIX or APT?

Does the media favor IRIX or APT?

Do analysts prefer IRIX or APT?

Which has higher valuation & earnings, IRIX or APT?

Summary

How does IRIDEX compare to Spectral AI?

Do institutionals and insiders believe in IRIX or MDAI?

Which has stronger valuation & earnings, IRIX or MDAI?

Do analysts recommend IRIX or MDAI?

Is IRIX or MDAI more profitable?

Does the media prefer IRIX or MDAI?

Which has more volatility and risk, IRIX or MDAI?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

IRIX vs. The Competition

IRIDEX Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools